Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Guidant Mini III

This article was originally published in The Gray Sheet

Executive Summary

Guidant Mini III: Shipments of the 48 cc, 90 g single chamber pacer/implantable cardioverter defibrillator are anticipated to commence in March. Guidant received FDA approval via premarket approval application supplement on Jan. 23 and will ramp up manufacturing capability prior to shipping, the firm states. The device is a smaller version of the firm's 59 cc, 115 g Mini II, and incorporates Guidant's new Quick Check and Quick Notes features which "allow the clinician to easily and quickly perform a comprehensive series of automatic tests and follow-up device operations" to facilitate patient management, Guidant states. The device uses Guidant's Endotak lead and Triad three-electrode energy defibrillation system...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel